Population-based analysis of a novel prognostic model for metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with abiraterone acetate (AA).
Arun Azad
Honoraria - Janssen
Renee Lester
No relevant relationships to disclose
Raya Leibowitz-Amit
No relevant relationships to disclose
Anthony M. Joshua
Research Funding - Janssen-Ortho
Daniel Yick Chin Heng
No relevant relationships to disclose
Bernhard J. Eigl
Other Remuneration - Janssen
Kim N. Chi
Consultant or Advisory Role - Janssen
Research Funding - Janssen-Ortho